Cancer Stem Cell Single-Cell RNA-Seq Data Analysis Service
Creative Biolabs resolves tumor architectural complexity by moving beyond "average" bulk signals to pinpoint the precise cells driving metastasis and resistance. By isolating cancer stem cell (CSC)-specific signatures from thousands of heterogeneous cells, we address the "persister cell" problem, identifying quiescent subpopulations that evade chemotherapy. Our high-resolution lineage maps visualize how tumors evolve under therapeutic pressure, providing the biological justification for CAR-T or small-molecule development and ensuring your next clinical milestone is grounded in cellular reality.
Introduction to CSC Single-Cell Analysis
CSCs are the fundamental drivers of tumor heterogeneity, therapeutic evasion, and metastatic relapse. Recent high-impact literature emphasizes that CSCs are not static; they exist in a spectrum of states, with the "Hybrid E/M" intermediate state maximizing both signaling potential and metastatic fitness. Single-cell RNA-seq provides the only resolution high enough to capture the "circuit energy" of these regulatory networks and the bi-directional communication with the tumor microenvironment (TME). Creative Biolabs utilizes these peer-reviewed insights to provide a high-resolution lens into oncogenic engines, ensuring your therapeutic strategies target the most resilient and plastic cells in the tumor mass.
Strategic Analytical Capabilities: Tailored CSC Solutions
Beyond standard bioinformatics, Creative Biolabs offers specialized analytical modules designed to decode the specific biological properties of stemness. We provide a suite of unique capabilities that translate transcriptomic data into strategic therapeutic insights.
Machine Learning-Based Stemness Indexing (mRNAsi)
We implement algorithms to assign objective stemness scores to every cell. This identifies the core CSC population by their developmental potential rather than relying on inconsistent surface markers.
Hybrid E/M Intermediate State Analysis
Utilizing circuit energy modeling, we pinpoint high-risk "hybrid" cells that exhibit both epithelial and mesenchymal traits. These populations are the primary drivers of signaling intensification and metastatic fitness.
Lineage Tracing & RNA Velocity Dynamics
Our pipeline reconstructs the developmental hierarchy of the tumor, using RNA velocity to predict future cell states. This reveals the directionality of differentiation and identifies the cells initiating tumor regrowth.
CSC-Niche Interactome Mapping
We utilize advanced ligand-receptor analysis to map the bidirectional crosstalk between CSCs and the tumor microenvironment. This identifies the specific signaling axes, such as Notch and WNT, that sustain the niche.
Gene Regulatory Network (GRN) Reconstruction
By inferring transcription factor activity through analysis, we identify the "master regulators" maintaining the stem-like state. This highlights the most effective intracellular targets for small-molecule intervention.
Transform Your Raw Data into High-Value Therapeutic Leads – Inquire About Our Custom Analytical Packages
Workflow
The Creative Biolabs workflow is a comprehensive, multi-stage process that integrates computational prediction with functional biological evidence to provide a holistic view of patient response.
Publication
This study employs single-cell RNA sequencing in a YAP/AKT mouse model to dissect cholangiocarcinoma (CCA) progression. It identifies Tm4sf1-high malignant cells as cancer stem-like cells (CSCs) and characterizes their dynamic interactions with the tumor microenvironment. The work provides a comprehensive resource detailing CSC heterogeneity and evolving stromal-immune crosstalk during tumorigenesis, offering insights for potential therapeutic strategies.
Fig.1 Single-cell profiling of liver and cholangiocarcinoma in a YAP/AKT mouse model. 1
Why Choose Us?
Creative Biolabs stands as a global leader by integrating decades of oncology expertise with specialized machine-learning tools tailored for rare-cell identification. Unlike standard bioinformatics providers who rely on generic pipelines, we focus on the functional state of the cell using high-resolution spatial-temporal algorithms. We have successfully pioneered "circuit energy" analysis to identify hybrid epithelial-mesenchymal states that standard workflows often overlook, providing our clients with a distinct competitive advantage in precision target identification. Our PhD-level scientists combine deep biological insights with custom-built computational architectures to resolve complex tumor hierarchies, ensuring that every data point translates into a viable therapeutic lead.
Empower Your Oncology Pipeline with Expert Insights – Experience the Creative Biolabs Advantage & Get a Quote Today
FAQs
Can your service find CSCs without using known markers like CD44 or CD133?
Yes. Creative Biolabs uses machine-learning algorithms (mRNAsi) that score cells based on their global transcriptomic "stemness" profile, identifying CSCs through functional potential even when standard markers are absent.
How do you separate truly stem-like cells from those that are simply proliferating?
We employ functional state clustering that decouples cell cycle markers (G2/M) from core stemness GRNs, ensuring high specificity.
Can you analyze how CSCs communicate with the immune system?
Our interactome analysis specifically maps crosstalk between CSCs and immune populations, revealing how CSCs "educate" the TME to create an immunosuppressive niche.
Customer Review
-
Unprecedented Resolution
Using Creative Biolabs' analysis in our colorectal cancer research has significantly facilitated the identification of metabolic vulnerabilities in rare CSC subpopulations. The mRNAsi scoring was far more accurate than our previous surface-marker-only approach. - Dr. Mar** L -
Invaluable Interactome Data
We struggled to understand how our therapy was being bypassed until we utilized this interactome mapping. The visualization of the CXCL12–DPP4 interaction between CSCs and fibroblasts provided the missing link in our TME study. - Prof. Tho** H
Related Services
Cancer Stem Cell Patient Stratification & Response Prediction
Creative Biolabs utilizes CSR scores, integrating scRNA-seq and m6A mapping to identify quiescent CSCs. We stratify patient cohorts by predicting therapeutic failure and metastatic spread in immune-cold/hot environments.
Learn More →Tumor Profiling in Head and Neck Cancer
Creative Biolabs provides personalized profiling for head and neck cancers, utilizing single-cell technologies to map intra-tumoral heterogeneity and TME immunosuppression. We identify biomarkers to overcome metastasis and drug resistance.
Learn More →How to Contact Creative Biolabs
Creative Biolabs is dedicated to providing the most advanced CSC scRNA-seq data analysis to empower your oncology programs. From identifying rare hybrid states to mapping the complex signaling of the CSC niche, our PhD-level scientists ensure your data is translated into therapeutic progress.
Bridge the Gap Between Raw Sequencing and Clinical Success – Contact Our Team for More Information and to Discuss Your Project
Reference
- Golino, Jihye L., et al. "Single-cell RNA sequencing reveals cancer stem-like cells and dynamics in tumor microenvironment during cholangiocarcinoma progression." Frontiers in Cell and Developmental Biology 11 (2023): 1250215. Distributed under Open Access license CC BY 4.0, without modification. https://doi.org/10.3389/fcell.2023.1250215
Download our brochure